Understanding the effects and risks of bath salts and their variants
Cross platform analysis of drug targets and toxicity of bath salts
['FUNDING_U01'] · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · NIH-10870155
This study is looking into how 'bath salts' affect the brain and body, aiming to understand their risks and help improve treatment for people who struggle with substance use.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS (nih funded) |
| Locations | 1 site (TOLEDO, UNITED STATES) |
| Trial ID | NIH-10870155 on ClinicalTrials.gov |
What this research studies
This research investigates the addictive properties and toxic effects of a group of substances known as 'bath salts', which are often used recreationally. The study aims to analyze how these substances interact with the brain and body at a molecular level, using advanced techniques to identify their drug targets and potential risks. By synthesizing specific probes and conducting detailed assays, the research seeks to provide insights that could help in treating substance abuse disorders and managing acute toxicity. Patients may benefit from a better understanding of the risks associated with these substances and improved treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who have experienced adverse effects from using bath salts or similar substances.
Not a fit: Patients who do not use bath salts or have not experienced any related adverse effects may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for individuals suffering from substance abuse disorders related to bath salts.
How similar studies have performed: While there has been substantial research into the effects of some psychoactive substances, this specific approach using photoaffinity labeling is relatively novel and untested.
Where this research is happening
TOLEDO, UNITED STATES
- UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS — TOLEDO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SCHIEFER, ISAAC T — UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
- Study coordinator: SCHIEFER, ISAAC T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.